首页 > 市场调查报告书 > 製药

感染疾病

全球抗菌素耐药性诊断市场规模、份额和行业趋势分析报告：按技术、最终用户、病原体、地区划分的展望和预测，2022-2028 年

市场调查报告书

商品编码

1172701

全球抗菌素耐药性诊断市场规模、份额和行业趋势分析报告：按技术、最终用户、病原体、地区划分的展望和预测，2022-2028 年

Global Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User, By Pathogen, By Regional Outlook and Forecast, 2022 - 2028

出版日期: 2022年11月30日 | 出版商:

KBV Research | 英文 288 Pages | 订单完成后即时交付

价格

简介目录图表

到 2028 年，全球耐药性诊断市场规模预计将达到 57 亿美元，预测期内復合年增长率为 6.1%。

为了生存，细菌可以发展出一种机制，称为对抗生素和抗真菌剂的耐药性。细菌耐药机制由 DNA 指示细菌产生的特定蛋白质决定。细菌和真菌中存在各种形式的抗性基因。将耐药机製完美地结合到已经难以治疗的细菌中，会使所有抗生素和抗真菌药都失效，从而导致无法治癒的疾病。此外，对抗生素和抗真菌剂具有抗性的细菌可能会与其他细菌交换它们的抗性机制。

COVID-19 影响分析

COVID-19 大流行加剧了持续的全球抗菌素耐药性危机。这是由于越来越多地使用抗生素来诊断 COVID-19 患者、负担过重的卫生系统中感染控制和预防程序的中断，以及监测和应对 AMR 威胁的资源和资源的损失。这是由于滥用公共资源。由于 COVID-19，全球封锁使得虚拟访问和快速诊断测试成为必要，以避免患者去医院。即使在大流行之后，家庭保健也被认为是重中之重，特别是对于已有疾病的人来说，这推动了对诊断的需求。因此，大流行对耐药诊断市场产生了总体积极影响。

市场增长因素

更好的诊断测试和试剂盒的可用性

最新的高速诊断成像技术可以在临床环境中更快地提供信息。传统的基于培养的技术需要在获得易感性数据之前培养孤立的菌落，这可能需要长达 48 小时或更长时间。无需传统培养程序即可揭示耐药性的新研究方法可以将这一时间缩短至少一天，在某些情况下甚至更多。

院内感染增加

尚未发生或入院时尚未发生的医院获得性感染称为医院获得性感染 (HAI)。这些感染包括与中央静脉管路相关的血流感染、使用导尿管引起的尿路感染、许多手术部位感染、呼吸机效应引起的肺炎、医院获得性肺炎、CD 感染等。现代医疗保健使用各种技术和设备来帮助治疗和治愈患者。

市场约束

目前的测试提供了一组有限的耐药决定因素

大多数用于检测抗菌素耐药性的商用快速检测都是依赖于寻找基因产物或耐药基因的基因型检测。这种方法有一些缺点。首先，虽然基因分型方法可用于预测抗生素耐药性，但它们不提供有关抗菌素敏感性的信息。此外，这些方法仅评估相对较小的电阻决定因素组，并且只为您提供您正在寻找的内容。

技术展望

耐药性诊断市场根据技术细分为微生物培养、免疫测定、PCR、NGS、质谱、快速和即时护理等。 2021年，耐药诊断市场将由PCR板块主导。导致高市场份额的主要因素是PCR技术的发展及其由于其出色的准确性而广泛传播。由于对艰难梭菌和 MRSA 等医院获得性感染 (HAI) 的 PCR 诊断越来越频繁地使用，该领域也在不断发展。

最终用户视角

抗菌素耐药性诊断市场根据最终用户细分为医院、诊断实验室、製药和生物技术公司等。诊断实验室在 2021 年的耐药诊断市场取得了显着的增长。传染病的日益流行和实验室技术的发展预计将推动该领域的扩张。此外，诊断专业实验室的高渗透率和价格合理的服务预计将支持市场的增长。

病原体的前景

耐药诊断市场按病原体划分为耐药肺炎链球菌 (DRSP)、耐药弯曲桿菌 (DRC)、艰难梭菌 (CD)、耐甲氧西林金黄色葡萄球菌 (MRSA)、耐药淋球菌(DRNG), 它被归类为耐药沙门氏菌 (DRNTS)。 2021 年，耐甲氧西林金黄色葡萄球菌 (MRSA) 细分市场在耐药诊断市场中的收入份额最高。细分市场增长的主要驱动力是 MRSA 在医院环境中的流行率上升。此外，越来越多的批准用于检测 MRSA 的诊断测试也是市场驱动力之一。

区域展望

按地区划分，分析了北美、欧洲、亚太地区和 LAMEA 的耐药性诊断市场。北美市场在 2021 年占据了耐药诊断市场最大的收入份额。产生抗生素耐药性的高风险、有利的政府抗击 AMR 政策以及最先进的医疗基础设施的存在是推动北美地区增长的因素之一。

合作伙伴关係是市场进入者采取的主要策略。根据发表在 Cardinal Matrix 上的分析，F. Hoffmann-La Roche 正在引领耐药性诊断市场。 Abbott Laboratories、Danaher Corporation 和 BioMerieux S.A. 等公司是耐药性诊断市场的领先创新者。

内容

第一章市场范围与研究方法

市场定义
目的
市场规模
细分
- 全球抗菌素耐药性诊断市场，按技术分类
- 全球抗菌素耐药性诊断市场，按最终用户分类
- 全球抗菌素耐药性诊断市场：按病原体分类
- 全球抗菌素耐药性诊断市场，按地区
调查方法

第 2 章市场概述

简介
- 简介
  - 市场构成和情景
影响市场的主要因素
- 市场驱动因素
- 市场製约因素

第 3 章竞争分析 - 世界

KBV 基数矩阵
近期的全行业战略发展
- 伙伴关係、协作和合同
- 产品发布和产品扩展
- 收购与合併
关键成功策略
- 主要领先战略：比例分布（2018-2022 年）

第 4 章全球抗菌素耐药性诊断市场：按技术分类

全球 PCR 市场：按地区
全球免疫分析市场：按地区
NGS 全球市场：按地区分类
全球微生物培养市场：按地区
全球质谱市场：按地区
全球快速和即时护理市场：按地区
世界其他地区市场

第 5 章全球耐药性诊断市场：按最终用户分类

全球医院区域市场
全球诊断实验室市场，按地区
全球製药公司、生物技术公司和其他区域市场

第 6 章全球抗菌素耐药性诊断市场：按病原体分类

耐甲氧西林金黄色葡萄球菌 (MRSA) 全球市场：按地区
全球艰难梭菌 (CD) 市场：按地区
全球耐药弯曲桿菌 (DRC) 市场：按地区
全球耐药性肺炎球菌 (DRSP) 市场：按地区
全球耐药性淋病奈瑟菌 (DRNG) 市场：按地区
全球耐药沙门氏菌 (DRNTS) 市场：按地区
全球各地区的其他市场

第 7 章。全球抗菌素耐药性诊断市场：按地区分类

北美
- 北美抗菌素耐药性诊断市场（按国家/地区划分）
  - 美国
  - 加拿大
  - 墨西哥
  - 其他北美地区
欧洲
- 按国家/地区划分的欧洲耐药性诊断市场
  - 德国
  - 英国
  - 法国
  - 俄罗斯
  - 西班牙
  - 意大利
  - 其他欧洲
亚太地区
- 亚太地区抗菌素耐药性诊断的国家/地区市场
  - 中国
  - 日本
  - 印度
  - 韩国
  - 新加坡
  - 马来西亚
  - 其他亚太地区
拉美
- 按国家/地区划分的 LAMEA 抗菌素耐药性诊断市场
  - 巴西
  - 阿根廷
  - 阿联酋
  - 沙特阿拉伯
  - 南非
  - 尼日利亚
  - LAMEA 的其余部分

第八章公司简介

Abbott Laboratories
Becton, Dickinson and Company
BioMerieux S.A
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Hologic, Inc.
Vela Diagnostics Pte. Ltd.（Luye Medical Group Co., Ltd）
Molsid SAS
Visby Medical, Inc.
Accelerated Technology Laboratories, Inc.

简介目录图表

The Global Antimicrobial Resistance Diagnostics Market size is expected to reach $5.7 billion by 2028, rising at a market growth of 6.1% CAGR during the forecast period.

Antimicrobial medicines are given to combat the negative effects of microbes for a healthy life, but the overuse of these drugs leads to the development of resistance towards these medicines. This resistance is commonly termed antimicrobial resistance. The formation of resistant microbes is a natural occurrence, but the excessive or improper use of antimicrobials has significantly influenced the evolution of resistance.

Antimicrobial resistance has become the biggest danger to public health and is considered a global burden. Effective treatment plans can be guided by rapid diagnostic tests that pinpoint microorganisms with a high risk of developing drug resistance, assess antimicrobial susceptibility, and separate viral from bacterial infections. Rapid diagnostic tests also make epidemiological surveillance easier by allowing for the monitoring of developing resistant infectious pathogens and their transmission.

In order to survive, bacteria can create mechanisms known as resistance against antibiotics and antifungals. The germ's resistance mechanisms are determined by the specific proteins that DNA instructs the germ to produce. Many different forms of resistance genes can be found in bacteria and fungi. The perfect confluence of resistance mechanisms in bacteria that are already difficult to treat can render all antibiotics and antifungals useless, leading to illnesses that are untreatable. Unsettlingly, bacteria that are resistant to antibiotics and antifungals might exchange such resistance mechanisms with some other bacteria.

COVID-19 Impact Analysis

The COVID-19 pandemic exacerbated the ongoing antimicrobial resistance global crisis. This was because of the increased utilization of antibiotics to diagnose COVID-19 patients, disruptions to infection control and prevention procedures in overburdened health systems, and the diversion of financial and human resources away from surveilling and reacting to AMR threats. Because of COVID-19, the worldwide lockdown has made virtual visits and quick diagnostic testing necessary to help patients avoid going to the hospital. Even after the pandemic, it is projected that home-based healthcare will remain a top priority, especially for individuals with pre-existing diseases, which has facilitated the demand for diagnostic assays. Therefore, the pandemic had an overall positive impact on the antimicrobial resistance diagnostics market.

Market Growth Factor

Availability of Better Diagnostics Tests and Kits

Some brand-new, speedy image-based technologies can deliver information in a clinical situation more swiftly. The prevailing culture-based techniques that necessitate isolated colonies to increase before susceptibility data could be obtained can take up to 48 hours or more. New methodologies that reveal drug resistance without the use of conventional culture procedures can reduce that time frame by at minimum one day and possibly more.

Increasing Incidences of Hospital-Acquired Infections

Nosocomially acquired illnesses that are not existing or hatching at the moment of admission to a hospital are known as hospital-acquired infections (HAIs). These infections may include bloodstream infections that are joined to central lines, or urinary tract infections caused by use of catheters, many surgical site infections, ventilators influenced pneumonia, or pneumonia acquired in hospitals, and infections with CD. Many different intrusive techniques and equipment are used in modern healthcare to cure patients and aid in their recovery.

Market Restraining Factor

Limited Panel of Resistance Determinants Offered by Current Tests

The majority of commercially available quick tests for detecting antimicrobial resistance include genotypic tests, which rely on finding gene products or resistance genes. These methods have a number of drawbacks. The first is that while genotypic approaches can be useful for anticipating antibiotic resistance, they do not provide information on antimicrobial susceptibility. Also, these methods only give what is being looked for that is, typically a relatively small panel of resistance determinants is evaluated.

Technology Outlook

Based on technology, the antimicrobial resistance diagnostics market is categorized into microbiology culture, immunoassay, PCR, NGS, mass spectroscopy, rapid & point of care, and others. The PCR segment dominated the revenue share in the antimicrobial resistance diagnostics market in 2021. The main elements leading to the high sector share include developments in PCR technology and PCR technology's wide penetration because of its excellent accuracy. The segment is also growing as a result of PCR diagnostics for hospital-acquired infections (HAIs) like C. difficile and MRSA being used more frequently.

End User Outlook

Based on end user, the antimicrobial resistance diagnostics market is segmented into hospitals, diagnostic laboratories, pharmaceutical & biotechnology companies, and others. The diagnostic laboratories garnered a remarkable growth rate in the antimicrobial resistance diagnostics market in 2021. It is anticipated that the growing prevalence of infectious disorders and laboratory technical developments will fuel segment expansion. Additionally, high penetration of diagnostic-focused laboratories and reasonably priced services are expected to support market growth.

Pathogen Outlook

On the basis of pathogen, the antimicrobial resistance diagnostics market is divided into drug resistant streptococcus pneumonia (DRSP), drug resistant campylobacter (DRC), clostridium difficile (CD), methicillin resistant staphylococcus aureus (MRSA), drug resistant Neisseria gonorrhoeae (DRNG), drug resistant salmonella (DRNTS), and others. The methicillin resistant staphylococcus aureus (MRSA) segment garnered the highest revenue share in the antimicrobial resistance diagnostics market in 2021. The primary driver of segment expansion is the rising prevalence of MRSA in hospital settings. Additionally, a rise in the number of authorizations for diagnostic tests to find MRSA is another driver causing the market to grow.

Regional Outlook

On the basis of region, the antimicrobial resistance diagnostics market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the maximum revenue share in the antimicrobial resistance diagnostics market in 2021. The high danger of developing antibiotic resistance, favorable government policies to address AMR, and the existence of cutting-edge healthcare infrastructure are all factors contributing to the rise of the North American region.

The major strategies followed by the market participants are Partnerships. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. is the forerunner in the Antimicrobial Resistance Diagnostics Market. Companies such as Abbott Laboratories, Danaher Corporation, BioMerieux S.A. are some of the key innovators in Antimicrobial Resistance Diagnostics Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, BioMerieux S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Danaher Corporation, Accelerate Diagnostics, Inc., Hologic, Inc., Visby Medical, Inc., Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd) and Molsid S.A.S.

Recent Strategies Deployed in Antimicrobial Resistance Diagnostics Market

Partnership, Collaboration and Agreement:

Nov-2022: Danaher Corporation came into partnership with Duke University, a research University. Under this partnership, Danaher Corporation aimed to shape Danaher Beacon for the development of Gene Therapy Innovation.

Aug-2022: Becton, Dickinson, and Company entered into collaboration with Accelerate Diagnostics, Inc., a developer of rapid in-vitro diagnostics in microbiology. This Collaboration would enable the former company to help clinicians treat patients in a Constructive and organized way resulting in a decrease in costs in healthcare and helping restrict the stretch of antimicrobial resistance.

Feb-2022: F. Hoffmann-La Roche Ltd. teamed up with Mutabilis, a biopharmaceutical company. This collaboration aimed to create a further course of antibiotics to treat infections driven by WHO critical priority pathogens. Moreover, Companies would develop diagnostics and treatments to fight against infectious diseases.

Nov-2021: Roche signed an agreement with Venatorx Pharmaceuticals, a developer of antibacterial and antiviral drugs. The agreement aimed to find, illustrate and create small molecule inhibitors of the Penicillin Binding Proteins in Gram-negative bacteria focus agents active against carbapenem-resistant Enterobacterales (CRE).

Mar-2021: bioMerieux signed an agreement with GIZ, a Germany-based development agency. Under this Agreement, Companies will support Nigerian Center for Disease Control (NCDC) to combat Antimicrobial Resistance (AMR). Additionally, the agreement is aimed to advance the sensible use of antibiotics and execute antimicrobial stewardship programs.

Jun-2020: Roche signed an agreement with SpeeDx, a provider of clinical diagnostics. Through this Agreement, the companies aimed to Expand access to Antibiotic Resistance Tests. Additionally, SpeeDx would permit Roche Diagnostics to deliver clinicians with useful new tools for identifying antibiotic resistance in patients with sexually transmitted diseases.

Product Launch and Product Expansion:

May-2022: Vela Diagnostics launched PathoKey MP UTI ID and AMR PCR test, a PCR test to find UTI pathogens and AMR genes. The product aligns with real-time PCR cyclers consisting of QuantStudio 5 real-time PCR system and Rotor-Gene Q 5/6 plex platforms. Additionally, this launch aimed for in vitro observation and recognition of 14 antimicrobial resistance (AMR) genes also 14 pathogens that cause urinary tract infections (UTI) encoding resistance to five antibiotics.

Oct-2021: Hologic, Inc. announced the launch of the Novodiag system, a comprehensive automated molecular diagnostic solution for in-time testing of antimicrobial resistance and infectious diseases. The launch of the Novodiag system to Hologic's diagnostic molecular scalable solutions offerings would deliver customers across Europe a wide range of solutions from population-level screening to single-patient rapid testing.

May-2020: Vela Diagnostics unveiled ViroKey SQ FLEX Genotyping Assay, a Vela Diagnostics' FLEX portfolio product to offer workable automated solutions for qPCR and NGS to laboratories. This launch is aimed at Detects Drug Resistance Mutations in Human Immunodeficiency Virus, Hepatitis C Virus, Hepatitis B Virus, and Cytomegalovirus.

Acquisition, Joint Venture and Merger:

Jul-2022: bioMerieux, Boehringer Ingelheim, a biopharmaceutical company, and Evotec SE, a drug discovery and development company, signed an agreement. Following this agreement, the companies formed a joint venture company, Aurobac Therapeutics SAS. This Joint-Venture is aimed to develop precision medicine from diagnosis to cure against Antimicrobial resistance, a vital threat to public health.

May-2022: bioMerieux took-over Specific Diagnostics, a developer of a rapid antimicrobial susceptibility test (AST) system. This acquisition broadens bioMerieux's global position in Antimicrobial Resistance and clinical microbiology.

Sep-2021: Abbott completed the acquisition of Walk Vascular, a medical device company. This acquisition strengthened Abbott's vascular device portfolio and advanced its capabilities to offer endovascular therapy solutions and enhance patient care.

Jun-2021: Hologic, Inc. acquired Mobidiag Oy, a developer in acute care, near-patient molecular diagnostic testing. Through this acquisition, Hologic would evolve into a varied global diagnostics field.

Jun-2021: Danaher Corporation completed the acquisition of Aldevron, a biotechnology company. Through this acquisition, Danaher Corporation broadened its ability in the genomic medicine area and helped in supporting customers and its goal to include more vaccines and life-saving therapies.

Mar-2021: Roche took over GenMark, a molecular diagnostics company. Under this acquisition, Roche aimed to grow its offering of molecular diagnostics with GenMark's experience in syndromic testing. Moreover, GenMark's ePlex systems would improve Roche's work in controlling antibiotic resistance and communicable diseases.

Scope of the Study

Market Segments covered in the Report:

By Technology

PCR
Immunoassay
NGS
Microbiology Culture
Mass Spectrometry
Rapid & Point of Care
Others

By End User

Hospitals
Diagnostic Laboratories
Pharmaceutical, Biotechnology Companies & Others

By Pathogen

Methicillin Resistant Staphylococcus Aureus (MRSA)
Clostridium Difficile (CD)
Drug Resistant Campylobacter (DRC)
Drug Resistant Streptococcus Pneumoniae (DRSP)
Drug Resistant Neisseria Gonorrhoeae (DRNG)
Drug Resistant Salmonella (DRNTS)
Others

By Geography

North America
- US
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA

Companies Profiled

Abbott Laboratories
BioMerieux S.A.
F. Hoffmann-La Roche Ltd.
Becton, Dickinson and Company
Danaher Corporation
Accelerate Diagnostics, Inc.
Hologic, Inc.
Visby Medical, Inc.
Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
Molsid S.A.S.

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Global Antimicrobial Resistance Diagnostics Market, by Technology
- 1.4.2 Global Antimicrobial Resistance Diagnostics Market, by End User
- 1.4.3 Global Antimicrobial Resistance Diagnostics Market, by Pathogen
- 1.4.4 Global Antimicrobial Resistance Diagnostics Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview

2.1 Introduction
- 2.1.1 Overview
  - 2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Antimicrobial Resistance Diagnostics Market by Technology

4.1 Global PCR Market by Region
4.2 Global Immunoassay Market by Region
4.3 Global NGS Market by Region
4.4 Global Microbiology Culture Market by Region
4.5 Global Mass Spectrometry Market by Region
4.6 Global Rapid & Point of Care Market by Region
4.7 Global Others Market by Region

Chapter 5. Global Antimicrobial Resistance Diagnostics Market by End-user

5.1 Global Hospitals Market by Region
5.2 Global Diagnostic Laboratories Market by Region
5.3 Global Pharmaceutical, Biotechnology Companies & Others Market by Region

Chapter 6. Global Antimicrobial Resistance Diagnostics Market by Pathogen

6.1 Global Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Region
6.2 Global Clostridium Difficile (CD) Market by Region
6.3 Global Drug Resistant Campylobacter (DRC) Market by Region
6.4 Global Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Region
6.5 Global Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Region
6.6 Global Drug Resistant Salmonella (DRNTS) Market by Region
6.7 Global Others Market by Region

Chapter 7. Global Antimicrobial Resistance Diagnostics Market by Region

7.1 North America Antimicrobial Resistance Diagnostics Market
- 7.1.1 North America Antimicrobial Resistance Diagnostics Market by Technology
  - 7.1.1.1 North America PCR Market by Country
  - 7.1.1.2 North America Immunoassay Market by Country
  - 7.1.1.3 North America NGS Market by Country
  - 7.1.1.4 North America Microbiology Culture Market by Country
  - 7.1.1.5 North America Mass Spectrometry Market by Country
  - 7.1.1.6 North America Rapid & Point of Care Market by Country
  - 7.1.1.7 North America Others Market by Country
- 7.1.2 North America Antimicrobial Resistance Diagnostics Market by End-user
  - 7.1.2.1 North America Hospitals Market by Country
  - 7.1.2.2 North America Diagnostic Laboratories Market by Country
  - 7.1.2.3 North America Pharmaceutical, Biotechnology Companies & Others Market by Country
- 7.1.3 North America Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.1.3.1 North America Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
  - 7.1.3.2 North America Clostridium Difficile (CD) Market by Country
  - 7.1.3.3 North America Drug Resistant Campylobacter (DRC) Market by Country
  - 7.1.3.4 North America Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
  - 7.1.3.5 North America Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
  - 7.1.3.6 North America Drug Resistant Salmonella (DRNTS) Market by Country
  - 7.1.3.7 North America Others Market by Country
- 7.1.4 North America Antimicrobial Resistance Diagnostics Market by Country
  - 7.1.4.1 US Antimicrobial Resistance Diagnostics Market
    - 7.1.4.1.1 US Antimicrobial Resistance Diagnostics Market by Technology
    - 7.1.4.1.2 US Antimicrobial Resistance Diagnostics Market by End-user
    - 7.1.4.1.3 US Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.1.4.2 Canada Antimicrobial Resistance Diagnostics Market
    - 7.1.4.2.1 Canada Antimicrobial Resistance Diagnostics Market by Technology
    - 7.1.4.2.2 Canada Antimicrobial Resistance Diagnostics Market by End-user
    - 7.1.4.2.3 Canada Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.1.4.3 Mexico Antimicrobial Resistance Diagnostics Market
    - 7.1.4.3.1 Mexico Antimicrobial Resistance Diagnostics Market by Technology
    - 7.1.4.3.2 Mexico Antimicrobial Resistance Diagnostics Market by End-user
    - 7.1.4.3.3 Mexico Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.1.4.4 Rest of North America Antimicrobial Resistance Diagnostics Market
    - 7.1.4.4.1 Rest of North America Antimicrobial Resistance Diagnostics Market by Technology
    - 7.1.4.4.2 Rest of North America Antimicrobial Resistance Diagnostics Market by End-user
    - 7.1.4.4.3 Rest of North America Antimicrobial Resistance Diagnostics Market by Pathogen
7.2 Europe Antimicrobial Resistance Diagnostics Market
- 7.2.1 Europe Antimicrobial Resistance Diagnostics Market by Technology
  - 7.2.1.1 Europe PCR Market by Country
  - 7.2.1.2 Europe Immunoassay Market by Country
  - 7.2.1.3 Europe NGS Market by Country
  - 7.2.1.4 Europe Microbiology Culture Market by Country
  - 7.2.1.5 Europe Mass Spectrometry Market by Country
  - 7.2.1.6 Europe Rapid & Point of Care Market by Country
  - 7.2.1.7 Europe Others Market by Country
- 7.2.2 Europe Antimicrobial Resistance Diagnostics Market by End-user
  - 7.2.2.1 Europe Hospitals Market by Country
  - 7.2.2.2 Europe Diagnostic Laboratories Market by Country
  - 7.2.2.3 Europe Pharmaceutical, Biotechnology Companies & Others Market by Country
- 7.2.3 Europe Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.2.3.1 Europe Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
  - 7.2.3.2 Europe Clostridium Difficile (CD) Market by Country
  - 7.2.3.3 Europe Drug Resistant Campylobacter (DRC) Market by Country
  - 7.2.3.4 Europe Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
  - 7.2.3.5 Europe Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
  - 7.2.3.6 Europe Drug Resistant Salmonella (DRNTS) Market by Country
  - 7.2.3.7 Europe Others Market by Country
- 7.2.4 Europe Antimicrobial Resistance Diagnostics Market by Country
  - 7.2.4.1 Germany Antimicrobial Resistance Diagnostics Market
    - 7.2.4.1.1 Germany Antimicrobial Resistance Diagnostics Market by Technology
    - 7.2.4.1.2 Germany Antimicrobial Resistance Diagnostics Market by End-user
    - 7.2.4.1.3 Germany Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.2.4.2 UK Antimicrobial Resistance Diagnostics Market
    - 7.2.4.2.1 UK Antimicrobial Resistance Diagnostics Market by Technology
    - 7.2.4.2.2 UK Antimicrobial Resistance Diagnostics Market by End-user
    - 7.2.4.2.3 UK Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.2.4.3 France Antimicrobial Resistance Diagnostics Market
    - 7.2.4.3.1 France Antimicrobial Resistance Diagnostics Market by Technology
    - 7.2.4.3.2 France Antimicrobial Resistance Diagnostics Market by End-user
    - 7.2.4.3.3 France Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.2.4.4 Russia Antimicrobial Resistance Diagnostics Market
    - 7.2.4.4.1 Russia Antimicrobial Resistance Diagnostics Market by Technology
    - 7.2.4.4.2 Russia Antimicrobial Resistance Diagnostics Market by End-user
    - 7.2.4.4.3 Russia Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.2.4.5 Spain Antimicrobial Resistance Diagnostics Market
    - 7.2.4.5.1 Spain Antimicrobial Resistance Diagnostics Market by Technology
    - 7.2.4.5.2 Spain Antimicrobial Resistance Diagnostics Market by End-user
    - 7.2.4.5.3 Spain Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.2.4.6 Italy Antimicrobial Resistance Diagnostics Market
    - 7.2.4.6.1 Italy Antimicrobial Resistance Diagnostics Market by Technology
    - 7.2.4.6.2 Italy Antimicrobial Resistance Diagnostics Market by End-user
    - 7.2.4.6.3 Italy Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.2.4.7 Rest of Europe Antimicrobial Resistance Diagnostics Market
    - 7.2.4.7.1 Rest of Europe Antimicrobial Resistance Diagnostics Market by Technology
    - 7.2.4.7.2 Rest of Europe Antimicrobial Resistance Diagnostics Market by End-user
    - 7.2.4.7.3 Rest of Europe Antimicrobial Resistance Diagnostics Market by Pathogen
7.3 Asia Pacific Antimicrobial Resistance Diagnostics Market
- 7.3.1 Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology
  - 7.3.1.1 Asia Pacific PCR Market by Country
  - 7.3.1.2 Asia Pacific Immunoassay Market by Country
  - 7.3.1.3 Asia Pacific NGS Market by Country
  - 7.3.1.4 Asia Pacific Microbiology Culture Market by Country
  - 7.3.1.5 Asia Pacific Mass Spectrometry Market by Country
  - 7.3.1.6 Asia Pacific Rapid & Point of Care Market by Country
  - 7.3.1.7 Asia Pacific Others Market by Country
- 7.3.2 Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user
  - 7.3.2.1 Asia Pacific Hospitals Market by Country
  - 7.3.2.2 Asia Pacific Diagnostic Laboratories Market by Country
  - 7.3.2.3 Asia Pacific Pharmaceutical, Biotechnology Companies & Others Market by Country
- 7.3.3 Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.3.3.1 Asia Pacific Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
  - 7.3.3.2 Asia Pacific Clostridium Difficile (CD) Market by Country
  - 7.3.3.3 Asia Pacific Drug Resistant Campylobacter (DRC) Market by Country
  - 7.3.3.4 Asia Pacific Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
  - 7.3.3.5 Asia Pacific Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
  - 7.3.3.6 Asia Pacific Drug Resistant Salmonella (DRNTS) Market by Country
  - 7.3.3.7 Asia Pacific Others Market by Country
- 7.3.4 Asia Pacific Antimicrobial Resistance Diagnostics Market by Country
  - 7.3.4.1 China Antimicrobial Resistance Diagnostics Market
    - 7.3.4.1.1 China Antimicrobial Resistance Diagnostics Market by Technology
    - 7.3.4.1.2 China Antimicrobial Resistance Diagnostics Market by End-user
    - 7.3.4.1.3 China Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.3.4.2 Japan Antimicrobial Resistance Diagnostics Market
    - 7.3.4.2.1 Japan Antimicrobial Resistance Diagnostics Market by Technology
    - 7.3.4.2.2 Japan Antimicrobial Resistance Diagnostics Market by End-user
    - 7.3.4.2.3 Japan Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.3.4.3 India Antimicrobial Resistance Diagnostics Market
    - 7.3.4.3.1 India Antimicrobial Resistance Diagnostics Market by Technology
    - 7.3.4.3.2 India Antimicrobial Resistance Diagnostics Market by End-user
    - 7.3.4.3.3 India Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.3.4.4 South Korea Antimicrobial Resistance Diagnostics Market
    - 7.3.4.4.1 South Korea Antimicrobial Resistance Diagnostics Market by Technology
    - 7.3.4.4.2 South Korea Antimicrobial Resistance Diagnostics Market by End-user
    - 7.3.4.4.3 South Korea Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.3.4.5 Singapore Antimicrobial Resistance Diagnostics Market
    - 7.3.4.5.1 Singapore Antimicrobial Resistance Diagnostics Market by Technology
    - 7.3.4.5.2 Singapore Antimicrobial Resistance Diagnostics Market by End-user
    - 7.3.4.5.3 Singapore Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.3.4.6 Malaysia Antimicrobial Resistance Diagnostics Market
    - 7.3.4.6.1 Malaysia Antimicrobial Resistance Diagnostics Market by Technology
    - 7.3.4.6.2 Malaysia Antimicrobial Resistance Diagnostics Market by End-user
    - 7.3.4.6.3 Malaysia Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.3.4.7 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market
    - 7.3.4.7.1 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology
    - 7.3.4.7.2 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user
    - 7.3.4.7.3 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen
7.4 LAMEA Antimicrobial Resistance Diagnostics Market
- 7.4.1 LAMEA Antimicrobial Resistance Diagnostics Market by Technology
  - 7.4.1.1 LAMEA PCR Market by Country
  - 7.4.1.2 LAMEA Immunoassay Market by Country
  - 7.4.1.3 LAMEA NGS Market by Country
  - 7.4.1.4 LAMEA Microbiology Culture Market by Country
  - 7.4.1.5 LAMEA Mass Spectrometry Market by Country
  - 7.4.1.6 LAMEA Rapid & Point of Care Market by Country
  - 7.4.1.7 LAMEA Others Market by Country
- 7.4.2 LAMEA Antimicrobial Resistance Diagnostics Market by End-user
  - 7.4.2.1 LAMEA Hospitals Market by Country
  - 7.4.2.2 LAMEA Diagnostic Laboratories Market by Country
  - 7.4.2.3 LAMEA Pharmaceutical, Biotechnology Companies & Others Market by Country
- 7.4.3 LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.4.3.1 LAMEA Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country
  - 7.4.3.2 LAMEA Clostridium Difficile (CD) Market by Country
  - 7.4.3.3 LAMEA Drug Resistant Campylobacter (DRC) Market by Country
  - 7.4.3.4 LAMEA Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country
  - 7.4.3.5 LAMEA Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country
  - 7.4.3.6 LAMEA Drug Resistant Salmonella (DRNTS) Market by Country
  - 7.4.3.7 LAMEA Others Market by Country
- 7.4.4 LAMEA Antimicrobial Resistance Diagnostics Market by Country
  - 7.4.4.1 Brazil Antimicrobial Resistance Diagnostics Market
    - 7.4.4.1.1 Brazil Antimicrobial Resistance Diagnostics Market by Technology
    - 7.4.4.1.2 Brazil Antimicrobial Resistance Diagnostics Market by End-user
    - 7.4.4.1.3 Brazil Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.4.4.2 Argentina Antimicrobial Resistance Diagnostics Market
    - 7.4.4.2.1 Argentina Antimicrobial Resistance Diagnostics Market by Technology
    - 7.4.4.2.2 Argentina Antimicrobial Resistance Diagnostics Market by End-user
    - 7.4.4.2.3 Argentina Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.4.4.3 UAE Antimicrobial Resistance Diagnostics Market
    - 7.4.4.3.1 UAE Antimicrobial Resistance Diagnostics Market by Technology
    - 7.4.4.3.2 UAE Antimicrobial Resistance Diagnostics Market by End-user
    - 7.4.4.3.3 UAE Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.4.4.4 Saudi Arabia Antimicrobial Resistance Diagnostics Market
    - 7.4.4.4.1 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Technology
    - 7.4.4.4.2 Saudi Arabia Antimicrobial Resistance Diagnostics Market by End-user
    - 7.4.4.4.3 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.4.4.5 South Africa Antimicrobial Resistance Diagnostics Market
    - 7.4.4.5.1 South Africa Antimicrobial Resistance Diagnostics Market by Technology
    - 7.4.4.5.2 South Africa Antimicrobial Resistance Diagnostics Market by End-user
    - 7.4.4.5.3 South Africa Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.4.4.6 Nigeria Antimicrobial Resistance Diagnostics Market
    - 7.4.4.6.1 Nigeria Antimicrobial Resistance Diagnostics Market by Technology
    - 7.4.4.6.2 Nigeria Antimicrobial Resistance Diagnostics Market by End-user
    - 7.4.4.6.3 Nigeria Antimicrobial Resistance Diagnostics Market by Pathogen
  - 7.4.4.7 Rest of LAMEA Antimicrobial Resistance Diagnostics Market
    - 7.4.4.7.1 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Technology
    - 7.4.4.7.2 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by End-user
    - 7.4.4.7.3 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen

Chapter 8. Company Profiles

8.1 Abbott Laboratories
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 Recent strategies and developments:
  - 8.1.5.1 Acquisition and Mergers:
- 8.1.6 SWOT Analysis
8.2 Becton, Dickinson and Company
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
  - 8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 BioMerieux S.A.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 Recent strategies and developments:
  - 8.3.5.1 Partnerships, Collaborations, and Agreements:
  - 8.3.5.2 Acquisition, Joint Ventures and Mergers:
8.4 F. Hoffmann-La Roche Ltd.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expense
- 8.4.5 Recent strategies and developments:
  - 8.4.5.1 Partnerships, Collaborations, and Agreements:
  - 8.4.5.2 Acquisition and Mergers:
8.5 Danaher Corporation
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 Recent strategies and developments:
  - 8.5.5.1 Partnerships, Collaborations, and Agreements:
  - 8.5.5.2 Acquisition and Mergers:
8.6 Hologic, Inc.
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Financial Analysis
- 8.6.4 Segmental and Regional Analysis
- 8.6.5 Recent strategies and developments:
  - 8.6.5.1 Product Launches and Product Expansions:
  - 8.6.5.2 Acquisition and Mergers:
8.7 Vela Diagnostics Pte. Ltd. (Luye Medical Group Co., Ltd)
- 8.7.1 Company Overview
- 8.7.2 Recent strategies and developments:
  - 8.7.2.1 Product Launches and Product Expansions:
8.8 Molsid SAS
- 8.8.1 Company Overview
8.9 Visby Medical, Inc.
- 8.9.1 Company Overview
8.10. Accelerated Technology Laboratories, Inc.
- 8.10.1 Company Overview

简介目录图表

LIST OF TABLES

TABLE 1 Global Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 2 Global Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Antimicrobial Resistance Diagnostics Market
TABLE 4 Product Launches And Product Expansions- Antimicrobial Resistance Diagnostics Market
TABLE 5 Acquisition and Mergers- Antimicrobial Resistance Diagnostics Market
TABLE 6 Global Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 7 Global Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 8 Global PCR Market by Region, 2018 - 2021, USD Million
TABLE 9 Global PCR Market by Region, 2022 - 2028, USD Million
TABLE 10 Global Immunoassay Market by Region, 2018 - 2021, USD Million
TABLE 11 Global Immunoassay Market by Region, 2022 - 2028, USD Million
TABLE 12 Global NGS Market by Region, 2018 - 2021, USD Million
TABLE 13 Global NGS Market by Region, 2022 - 2028, USD Million
TABLE 14 Global Microbiology Culture Market by Region, 2018 - 2021, USD Million
TABLE 15 Global Microbiology Culture Market by Region, 2022 - 2028, USD Million
TABLE 16 Global Mass Spectrometry Market by Region, 2018 - 2021, USD Million
TABLE 17 Global Mass Spectrometry Market by Region, 2022 - 2028, USD Million
TABLE 18 Global Rapid & Point of Care Market by Region, 2018 - 2021, USD Million
TABLE 19 Global Rapid & Point of Care Market by Region, 2022 - 2028, USD Million
TABLE 20 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 21 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 22 Global Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 23 Global Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 24 Global Hospitals Market by Region, 2018 - 2021, USD Million
TABLE 25 Global Hospitals Market by Region, 2022 - 2028, USD Million
TABLE 26 Global Diagnostic Laboratories Market by Region, 2018 - 2021, USD Million
TABLE 27 Global Diagnostic Laboratories Market by Region, 2022 - 2028, USD Million
TABLE 28 Global Pharmaceutical, Biotechnology Companies & Others Market by Region, 2018 - 2021, USD Million
TABLE 29 Global Pharmaceutical, Biotechnology Companies & Others Market by Region, 2022 - 2028, USD Million
TABLE 30 Global Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 31 Global Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 32 Global Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Region, 2018 - 2021, USD Million
TABLE 33 Global Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Region, 2022 - 2028, USD Million
TABLE 34 Global Clostridium Difficile (CD) Market by Region, 2018 - 2021, USD Million
TABLE 35 Global Clostridium Difficile (CD) Market by Region, 2022 - 2028, USD Million
TABLE 36 Global Drug Resistant Campylobacter (DRC) Market by Region, 2018 - 2021, USD Million
TABLE 37 Global Drug Resistant Campylobacter (DRC) Market by Region, 2022 - 2028, USD Million
TABLE 38 Global Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Region, 2018 - 2021, USD Million
TABLE 39 Global Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Region, 2022 - 2028, USD Million
TABLE 40 Global Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Region, 2018 - 2021, USD Million
TABLE 41 Global Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Region, 2022 - 2028, USD Million
TABLE 42 Global Drug Resistant Salmonella (DRNTS) Market by Region, 2018 - 2021, USD Million
TABLE 43 Global Drug Resistant Salmonella (DRNTS) Market by Region, 2022 - 2028, USD Million
TABLE 44 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 45 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 46 Global Antimicrobial Resistance Diagnostics Market by Region, 2018 - 2021, USD Million
TABLE 47 Global Antimicrobial Resistance Diagnostics Market by Region, 2022 - 2028, USD Million
TABLE 48 North America Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 49 North America Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 50 North America Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 51 North America Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 52 North America PCR Market by Country, 2018 - 2021, USD Million
TABLE 53 North America PCR Market by Country, 2022 - 2028, USD Million
TABLE 54 North America Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 55 North America Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 56 North America NGS Market by Country, 2018 - 2021, USD Million
TABLE 57 North America NGS Market by Country, 2022 - 2028, USD Million
TABLE 58 North America Microbiology Culture Market by Country, 2018 - 2021, USD Million
TABLE 59 North America Microbiology Culture Market by Country, 2022 - 2028, USD Million
TABLE 60 North America Mass Spectrometry Market by Country, 2018 - 2021, USD Million
TABLE 61 North America Mass Spectrometry Market by Country, 2022 - 2028, USD Million
TABLE 62 North America Rapid & Point of Care Market by Country, 2018 - 2021, USD Million
TABLE 63 North America Rapid & Point of Care Market by Country, 2022 - 2028, USD Million
TABLE 64 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 65 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 66 North America Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 67 North America Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 68 North America Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 69 North America Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 70 North America Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 71 North America Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 72 North America Pharmaceutical, Biotechnology Companies & Others Market by Country, 2018 - 2021, USD Million
TABLE 73 North America Pharmaceutical, Biotechnology Companies & Others Market by Country, 2022 - 2028, USD Million
TABLE 74 North America Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 75 North America Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 76 North America Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2018 - 2021, USD Million
TABLE 77 North America Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2022 - 2028, USD Million
TABLE 78 North America Clostridium Difficile (CD) Market by Country, 2018 - 2021, USD Million
TABLE 79 North America Clostridium Difficile (CD) Market by Country, 2022 - 2028, USD Million
TABLE 80 North America Drug Resistant Campylobacter (DRC) Market by Country, 2018 - 2021, USD Million
TABLE 81 North America Drug Resistant Campylobacter (DRC) Market by Country, 2022 - 2028, USD Million
TABLE 82 North America Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2018 - 2021, USD Million
TABLE 83 North America Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2022 - 2028, USD Million
TABLE 84 North America Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2018 - 2021, USD Million
TABLE 85 North America Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2022 - 2028, USD Million
TABLE 86 North America Drug Resistant Salmonella (DRNTS) Market by Country, 2018 - 2021, USD Million
TABLE 87 North America Drug Resistant Salmonella (DRNTS) Market by Country, 2022 - 2028, USD Million
TABLE 88 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 89 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 90 North America Antimicrobial Resistance Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 91 North America Antimicrobial Resistance Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 92 US Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 93 US Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 94 US Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 95 US Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 96 US Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 97 US Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 98 US Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 99 US Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 100 Canada Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 101 Canada Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 102 Canada Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 103 Canada Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 104 Canada Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 105 Canada Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 106 Canada Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 107 Canada Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 108 Mexico Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 109 Mexico Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 110 Mexico Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 111 Mexico Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 112 Mexico Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 113 Mexico Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 114 Mexico Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 115 Mexico Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 116 Rest of North America Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 117 Rest of North America Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 118 Rest of North America Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 119 Rest of North America Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 120 Rest of North America Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 121 Rest of North America Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 122 Rest of North America Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 123 Rest of North America Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 124 Europe Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 125 Europe Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 126 Europe Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 127 Europe Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 128 Europe PCR Market by Country, 2018 - 2021, USD Million
TABLE 129 Europe PCR Market by Country, 2022 - 2028, USD Million
TABLE 130 Europe Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 131 Europe Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 132 Europe NGS Market by Country, 2018 - 2021, USD Million
TABLE 133 Europe NGS Market by Country, 2022 - 2028, USD Million
TABLE 134 Europe Microbiology Culture Market by Country, 2018 - 2021, USD Million
TABLE 135 Europe Microbiology Culture Market by Country, 2022 - 2028, USD Million
TABLE 136 Europe Mass Spectrometry Market by Country, 2018 - 2021, USD Million
TABLE 137 Europe Mass Spectrometry Market by Country, 2022 - 2028, USD Million
TABLE 138 Europe Rapid & Point of Care Market by Country, 2018 - 2021, USD Million
TABLE 139 Europe Rapid & Point of Care Market by Country, 2022 - 2028, USD Million
TABLE 140 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 141 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 142 Europe Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 143 Europe Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 144 Europe Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 145 Europe Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 146 Europe Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 147 Europe Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 148 Europe Pharmaceutical, Biotechnology Companies & Others Market by Country, 2018 - 2021, USD Million
TABLE 149 Europe Pharmaceutical, Biotechnology Companies & Others Market by Country, 2022 - 2028, USD Million
TABLE 150 Europe Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 151 Europe Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 152 Europe Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2018 - 2021, USD Million
TABLE 153 Europe Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2022 - 2028, USD Million
TABLE 154 Europe Clostridium Difficile (CD) Market by Country, 2018 - 2021, USD Million
TABLE 155 Europe Clostridium Difficile (CD) Market by Country, 2022 - 2028, USD Million
TABLE 156 Europe Drug Resistant Campylobacter (DRC) Market by Country, 2018 - 2021, USD Million
TABLE 157 Europe Drug Resistant Campylobacter (DRC) Market by Country, 2022 - 2028, USD Million
TABLE 158 Europe Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2018 - 2021, USD Million
TABLE 159 Europe Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2022 - 2028, USD Million
TABLE 160 Europe Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2018 - 2021, USD Million
TABLE 161 Europe Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2022 - 2028, USD Million
TABLE 162 Europe Drug Resistant Salmonella (DRNTS) Market by Country, 2018 - 2021, USD Million
TABLE 163 Europe Drug Resistant Salmonella (DRNTS) Market by Country, 2022 - 2028, USD Million
TABLE 164 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 165 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 166 Europe Antimicrobial Resistance Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 167 Europe Antimicrobial Resistance Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 168 Germany Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 169 Germany Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 170 Germany Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 171 Germany Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 172 Germany Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 173 Germany Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 174 Germany Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 175 Germany Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 176 UK Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 177 UK Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 178 UK Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 179 UK Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 180 UK Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 181 UK Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 182 UK Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 183 UK Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 184 France Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 185 France Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 186 France Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 187 France Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 188 France Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 189 France Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 190 France Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 191 France Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 192 Russia Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 193 Russia Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 194 Russia Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 195 Russia Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 196 Russia Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 197 Russia Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 198 Russia Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 199 Russia Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 200 Spain Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 201 Spain Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 202 Spain Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 203 Spain Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 204 Spain Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 205 Spain Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 206 Spain Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 207 Spain Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 208 Italy Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 209 Italy Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 210 Italy Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 211 Italy Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 212 Italy Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 213 Italy Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 214 Italy Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 215 Italy Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 216 Rest of Europe Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 217 Rest of Europe Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 218 Rest of Europe Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 219 Rest of Europe Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 220 Rest of Europe Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 221 Rest of Europe Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 222 Rest of Europe Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 223 Rest of Europe Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 224 Asia Pacific Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 225 Asia Pacific Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 226 Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 227 Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 228 Asia Pacific PCR Market by Country, 2018 - 2021, USD Million
TABLE 229 Asia Pacific PCR Market by Country, 2022 - 2028, USD Million
TABLE 230 Asia Pacific Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 231 Asia Pacific Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 232 Asia Pacific NGS Market by Country, 2018 - 2021, USD Million
TABLE 233 Asia Pacific NGS Market by Country, 2022 - 2028, USD Million
TABLE 234 Asia Pacific Microbiology Culture Market by Country, 2018 - 2021, USD Million
TABLE 235 Asia Pacific Microbiology Culture Market by Country, 2022 - 2028, USD Million
TABLE 236 Asia Pacific Mass Spectrometry Market by Country, 2018 - 2021, USD Million
TABLE 237 Asia Pacific Mass Spectrometry Market by Country, 2022 - 2028, USD Million
TABLE 238 Asia Pacific Rapid & Point of Care Market by Country, 2018 - 2021, USD Million
TABLE 239 Asia Pacific Rapid & Point of Care Market by Country, 2022 - 2028, USD Million
TABLE 240 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 241 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 242 Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 243 Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 244 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 245 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 246 Asia Pacific Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 247 Asia Pacific Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 248 Asia Pacific Pharmaceutical, Biotechnology Companies & Others Market by Country, 2018 - 2021, USD Million
TABLE 249 Asia Pacific Pharmaceutical, Biotechnology Companies & Others Market by Country, 2022 - 2028, USD Million
TABLE 250 Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 251 Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 252 Asia Pacific Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2018 - 2021, USD Million
TABLE 253 Asia Pacific Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2022 - 2028, USD Million
TABLE 254 Asia Pacific Clostridium Difficile (CD) Market by Country, 2018 - 2021, USD Million
TABLE 255 Asia Pacific Clostridium Difficile (CD) Market by Country, 2022 - 2028, USD Million
TABLE 256 Asia Pacific Drug Resistant Campylobacter (DRC) Market by Country, 2018 - 2021, USD Million
TABLE 257 Asia Pacific Drug Resistant Campylobacter (DRC) Market by Country, 2022 - 2028, USD Million
TABLE 258 Asia Pacific Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2018 - 2021, USD Million
TABLE 259 Asia Pacific Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2022 - 2028, USD Million
TABLE 260 Asia Pacific Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2018 - 2021, USD Million
TABLE 261 Asia Pacific Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2022 - 2028, USD Million
TABLE 262 Asia Pacific Drug Resistant Salmonella (DRNTS) Market by Country, 2018 - 2021, USD Million
TABLE 263 Asia Pacific Drug Resistant Salmonella (DRNTS) Market by Country, 2022 - 2028, USD Million
TABLE 264 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 265 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 266 Asia Pacific Antimicrobial Resistance Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 267 Asia Pacific Antimicrobial Resistance Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 268 China Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 269 China Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 270 China Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 271 China Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 272 China Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 273 China Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 274 China Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 275 China Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 276 Japan Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 277 Japan Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 278 Japan Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 279 Japan Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 280 Japan Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 281 Japan Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 282 Japan Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 283 Japan Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 284 India Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 285 India Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 286 India Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 287 India Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 288 India Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 289 India Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 290 India Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 291 India Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 292 South Korea Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 293 South Korea Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 294 South Korea Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 295 South Korea Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 296 South Korea Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 297 South Korea Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 298 South Korea Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 299 South Korea Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 300 Singapore Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 301 Singapore Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 302 Singapore Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 303 Singapore Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 304 Singapore Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 305 Singapore Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 306 Singapore Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 307 Singapore Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 308 Malaysia Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 309 Malaysia Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 310 Malaysia Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 311 Malaysia Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 312 Malaysia Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 313 Malaysia Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 314 Malaysia Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 315 Malaysia Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 316 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 317 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 318 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 319 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 320 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 321 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 322 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 323 Rest of Asia Pacific Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million

TABLE 324 LAMEA Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 325 LAMEA Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 326 LAMEA Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 327 LAMEA Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 328 LAMEA PCR Market by Country, 2018 - 2021, USD Million
TABLE 329 LAMEA PCR Market by Country, 2022 - 2028, USD Million
TABLE 330 LAMEA Immunoassay Market by Country, 2018 - 2021, USD Million
TABLE 331 LAMEA Immunoassay Market by Country, 2022 - 2028, USD Million
TABLE 332 LAMEA NGS Market by Country, 2018 - 2021, USD Million
TABLE 333 LAMEA NGS Market by Country, 2022 - 2028, USD Million
TABLE 334 LAMEA Microbiology Culture Market by Country, 2018 - 2021, USD Million
TABLE 335 LAMEA Microbiology Culture Market by Country, 2022 - 2028, USD Million
TABLE 336 LAMEA Mass Spectrometry Market by Country, 2018 - 2021, USD Million
TABLE 337 LAMEA Mass Spectrometry Market by Country, 2022 - 2028, USD Million
TABLE 338 LAMEA Rapid & Point of Care Market by Country, 2018 - 2021, USD Million
TABLE 339 LAMEA Rapid & Point of Care Market by Country, 2022 - 2028, USD Million
TABLE 340 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 341 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 342 LAMEA Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 343 LAMEA Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 344 LAMEA Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 345 LAMEA Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 346 LAMEA Diagnostic Laboratories Market by Country, 2018 - 2021, USD Million
TABLE 347 LAMEA Diagnostic Laboratories Market by Country, 2022 - 2028, USD Million
TABLE 348 LAMEA Pharmaceutical, Biotechnology Companies & Others Market by Country, 2018 - 2021, USD Million
TABLE 349 LAMEA Pharmaceutical, Biotechnology Companies & Others Market by Country, 2022 - 2028, USD Million
TABLE 350 LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 351 LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 352 LAMEA Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2018 - 2021, USD Million
TABLE 353 LAMEA Methicillin Resistant Staphylococcus Aureus (MRSA) Market by Country, 2022 - 2028, USD Million
TABLE 354 LAMEA Clostridium Difficile (CD) Market by Country, 2018 - 2021, USD Million
TABLE 355 LAMEA Clostridium Difficile (CD) Market by Country, 2022 - 2028, USD Million
TABLE 356 LAMEA Drug Resistant Campylobacter (DRC) Market by Country, 2018 - 2021, USD Million
TABLE 357 LAMEA Drug Resistant Campylobacter (DRC) Market by Country, 2022 - 2028, USD Million
TABLE 358 LAMEA Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2018 - 2021, USD Million
TABLE 359 LAMEA Drug Resistant Streptococcus Pneumoniae (DRSP) Market by Country, 2022 - 2028, USD Million
TABLE 360 LAMEA Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2018 - 2021, USD Million
TABLE 361 LAMEA Drug Resistant Neisseria Gonorrhoeae (DRNG) Market by Country, 2022 - 2028, USD Million
TABLE 362 LAMEA Drug Resistant Salmonella (DRNTS) Market by Country, 2018 - 2021, USD Million
TABLE 363 LAMEA Drug Resistant Salmonella (DRNTS) Market by Country, 2022 - 2028, USD Million
TABLE 364 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 365 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 366 LAMEA Antimicrobial Resistance Diagnostics Market by Country, 2018 - 2021, USD Million
TABLE 367 LAMEA Antimicrobial Resistance Diagnostics Market by Country, 2022 - 2028, USD Million
TABLE 368 Brazil Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 369 Brazil Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 370 Brazil Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 371 Brazil Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 372 Brazil Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 373 Brazil Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 374 Brazil Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 375 Brazil Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 376 Argentina Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 377 Argentina Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 378 Argentina Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 379 Argentina Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 380 Argentina Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 381 Argentina Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 382 Argentina Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 383 Argentina Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 384 UAE Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 385 UAE Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 386 UAE Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 387 UAE Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 388 UAE Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 389 UAE Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 390 UAE Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 391 UAE Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 392 Saudi Arabia Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 393 Saudi Arabia Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 394 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 395 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 396 Saudi Arabia Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 397 Saudi Arabia Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 398 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 399 Saudi Arabia Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 400 South Africa Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 401 South Africa Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 402 South Africa Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 403 South Africa Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 404 South Africa Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 405 South Africa Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 406 South Africa Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 407 South Africa Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 408 Nigeria Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 409 Nigeria Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 410 Nigeria Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 411 Nigeria Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 412 Nigeria Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 413 Nigeria Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 414 Nigeria Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 415 Nigeria Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 416 Rest of LAMEA Antimicrobial Resistance Diagnostics Market, 2018 - 2021, USD Million
TABLE 417 Rest of LAMEA Antimicrobial Resistance Diagnostics Market, 2022 - 2028, USD Million
TABLE 418 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2021, USD Million
TABLE 419 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Technology, 2022 - 2028, USD Million
TABLE 420 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2021, USD Million
TABLE 421 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by End-user, 2022 - 2028, USD Million
TABLE 422 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2021, USD Million
TABLE 423 Rest of LAMEA Antimicrobial Resistance Diagnostics Market by Pathogen, 2022 - 2028, USD Million
TABLE 424 Key Information - Abbott Laboratories
TABLE 425 Key information - Becton, Dickinson and Company
TABLE 426 Key information - BioMerieux S.A.
TABLE 427 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
TABLE 428 Key Information - Danaher Corporation
TABLE 429 Key information - Hologic, Inc.
TABLE 430 Key Information - Vela Diagnostics Pte. Ltd.
TABLE 431 Key Information - Molsid SAS
TABLE 432 Key Information - Visby Medical, Inc.
TABLE 433 key information - Accelerated Technology Laboratories, Inc.

List of Figures

FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Global Antimicrobial Resistance Diagnostics Market Share by Technology, 2021
FIG 5 Global Antimicrobial Resistance Diagnostics Market Share by Technology, 2028
FIG 6 Global Antimicrobial Resistance Diagnostics Market by Technology, 2018 - 2028, USD Million
FIG 7 Global Antimicrobial Resistance Diagnostics Market Share by End-user, 2021
FIG 8 Global Antimicrobial Resistance Diagnostics Market Share by End-user, 2028
FIG 9 Global Antimicrobial Resistance Diagnostics Market by End-user, 2018 - 2028, USD Million
FIG 10 Global Antimicrobial Resistance Diagnostics Market Share by Pathogen, 2021
FIG 11 Global Antimicrobial Resistance Diagnostics Market Share by Pathogen, 2028
FIG 12 Global Antimicrobial Resistance Diagnostics Market by Pathogen, 2018 - 2028, USD Million
FIG 13 Global Antimicrobial Resistance Diagnostics Market Share by Region, 2021
FIG 14 Global Antimicrobial Resistance Diagnostics Market Share by Region, 2028
FIG 15 Global Antimicrobial Resistance Diagnostics Market by Region, 2018 - 2028, USD Million
FIG 16 Swot analysis: Abbott laboratories
FIG 17 Recent strategies and developments: BioMerieux S.A.
FIG 18 Recent strategies and developments: F. Hoffmann-La Roche Ltd.